Drug Repurposing: Perspective On An Emerging Pharmaceutical Solution
Source: Syngene International Ltd.
In this 60-minute interactive virtual exchange, we have Dr. Richard Mollard, MBA, Ph.D., Chief Scientific Officer, PharmAust Ltd in the hot seat, along with Kenneth Barr, Ph.D., Senior Vice President - Discovery Services, Syngene, and Host, Ashu Tandon, CCO, Syngene.
During the session, they discuss:
- Drug repurposing as an effective alternative approach to traditional Drug Discovery
- Changing Landscape: Drug repurposing gaining considerable momentum
- Steps in the Drug repurposing journey – moving to GMP scale
- Australian Pharmaceutical Industry Landscape
- Dynamics of working with an Indian CRO
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.
Subscribe to Drug Discovery Online
X
Subscribe to Drug Discovery Online
Syngene International Ltd.
This website uses cookies to ensure you get the best experience on our website. Learn more